Dr. Sloan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
830 Harrison Ave
Moakley, 3rd Floor
Boston, MA 02118Phone+1 617-638-6428Fax+1 617-638-5756
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2005 - 2008
- Yale-New Haven Medical CenterResidency, Internal Medicine, 2001 - 2004
- Yale School of MedicineClass of 2001
- Haverford CollegeBS, Physics, With High Honors, 1992 - 1996
Certifications & Licensure
- MA State Medical License 2005 - 2026
- CT State Medical License 2004 - 2005
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Evans Quality Improvement Award Boston University, 2013
- Physician Scholar in International Health Johnson and Johnson, 2003
- American Cancer Society Award American Cancer Society, 2001
- Join now to see all
Clinical Trials
- Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2013 Dec 09
- Etoposide in Patients With COVID-19 Infection Start of enrollment: 2020 May 08
Publications & Presentations
PubMed
- The Association of Anticoagulation Intensity with Outcomes in Hospitalized COVID-19 Patients.Rena Zheng, Alexandra Solomon, Madeline DiLorenzo, Iniya Rajendran, Joseph Park
Advances in Hematology. 2024-01-01 - Safety and Efficacy of Propylene Glycol-Free Melphalan in Patients with AL Amyloidosis Undergoing Autologous Stem Cell Transplantation: Results of a Phase II Study.Shayna Sarosiek, Michelle H Lee, Gheorghe Doros, Camille Vanessa Edwards, Karen Quillen
Transplantation and Cellular Therapy. 2023-11-01 - Successful dasatinib therapy in newly diagnosed chronic myeloid leukemia in the setting of short bowel syndrome.Jessica Freydman, Andrew Staron, David Hughes, John M Sloan
Journal of Oncology Pharmacy Practice. 2023-09-01
Journal Articles
- Heparin-Induced Thrombocytopenia and Thrombosis During High Dose Melphalan and Autologous Stem Cell TransplantationDina Brauneis, Vaishali Sanchorawala, J Mark Sloan, Shayna Sarosiek, Blood
- Beyond Methotrexate: Treatment of Residual Disease in Primary Central Nervous System LymphomaSloan JM, Hochberg E, Hochberg F, The American Journal of Hematology/Oncology, 1/1/2007
- Contrast mechanisms for scanning tunneling microscopy of biological moleculesSloan JM and Smith WF, Probe Microscopy, 1/1/1997
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- The Effect of Anticoagulant Choice on Venous Thromboembolism Recurrence and Bleeding in Sickle Cell DiseaseJohn Mark Sloan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Patients with Sickle Cell Disease and Venous Thromboembolism Experience Increased Frequency of Vasoocclusive EventsJohn Mark Sloan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Successful Transition from Bortezomib Subcutaneous (SubQ) to Generic Intravenous (IV) Bortezomib: Cost Savings Initiative with Global Economic ImpactJohn Mark Sloan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Safety, Tolerability and Response Rates of Daratumumab in Patients with Relapsed Light Chain (AL) Amyloidosis: Results of a Phase II Study2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- "Guest Speaker"Miami, FL - 1/10/2015
- "Medical Marijuana in Oncology: Benefits and potential pitfalls."6/18/2014
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: